Rekha Hemrajani - 17 Apr 2024 Form 4/A - Amendment Insider Report for BioAge Labs, Inc. (BIOA)

Role: Director
Signature: /s/ Dov A. Goldstein as attorney-in-fact
Issuer symbol: BIOA
Transactions as of: 17 Apr 2024
Net transactions value: +$54,000
Form type: 4/A - Amendment
Filing time: 10 Mar 2025, 16:11:28 UTC
Date Of Original Report: 27 Sep 2024
Previous filing: 23 Jun 2023
Next filing: 13 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIOA	Common Stock	Purchase	$54,000	+3,000		$18.00	3,000	27 Sep 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported securities were purchased through a directed share program in connection with the Issuer's initial public offering.

Remarks:

This Form 4 is being amended solely to report the purchase reflected in Table I above, which was inadvertently omitted from the Form 4 filed on September 27, 2024. The Form 4 filed on that date for the reporting person remains otherwise unmodified.